Metformin, the Diabetes Drug That May Prolong Life and Prevent Disease
A recent study has found that Metformin, a commonly prescribed drug for diabetes, may hold the key to prolonging life and preventing diseases such as cancer, cognitive decline, and heart disease. With a cost of less than a dollar a day for those with insurance, Metformin is a cost-effective option for many individuals looking to improve their health.
The TAME Trial, a six-year study aiming to enroll 3,000 adults aged between 65 and 79, has been created to investigate whether Metformin can slow down the aging process and prevent age-related diseases in older healthy adults. This trial comes on the heels of success stories like that of attorney Michael Cantor and his wife Shari Cantor, who credit Metformin with improving their overall lifestyle.
Michael began taking Metformin 10 years ago to manage his weight and blood sugar, while Shari started during the pandemic to potentially prevent infections. This coincides with the belief of aging researcher Steven Austad and other experts in the field, who suggest that Metformin may increase lifespan and lower the risk of various health issues.
While there have been reports of negative side effects such as trouble building new muscle and vitamin B deficiency, Michael and Shari have not experienced any adverse effects while taking Metformin. Austad and his colleagues have pushed for a clinical trial to gather more conclusive evidence and potentially prevent multiple health problems simultaneously.
As the TAME Trial progresses, more data is expected to shed light on the potential benefits of Metformin in aging and disease prevention. Stay tuned to KP Insider for the latest updates on this groundbreaking study.